pharmaceutical investing Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue
pharmaceutical investing Keryx Biopharmaceuticals Announces Publication of Data from the Phase 3 Trial of Auryxia
CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment